| Diversified Consumer Services Industry | Consumer Discretionary Sector | - CEO | TWSE Exchange | TW0006767007 ISIN |
| Taiwan Country | - Employees | - Last Dividend | - Last Split | - IPO Date |
Wiltrom Co., Ltd. stands out in the medical technology field, with its involvement deeply entrenched in the research, development, manufacturing, and international sale of implantable medical devices. Founded in 2009 and headquartered in Zhubei, Taiwan, Wiltrom has solidified its presence both within its home country and on a global scale. Through its innovative efforts, Wiltrom contributes significantly to advancing medical care for patients requiring specialized implantable devices.
Designed to provide stability and support to the spine during the post-operative healing process. These systems are essential for patients undergoing spinal fusion surgery, facilitating proper alignment and fusion of the vertebrae.
These systems play a critical role in spinal fusion surgeries, aiding in the fusion of two adjacent vertebrae through the insertion of an intervertebral device. It not only maintains vertebral spacing but also promotes bone growth between the vertebral bodies.
A vital component in orthopedic and spinal surgeries, bone graft substitutes are used to mimic the biological and structural characteristics of the natural bone. They provide a scaffold for new bone growth and are used when autograft (patient's own bone) is not an option.
These systems are employed in treating vertebral compression fractures. By stabilizing and restoring the height of the fractured vertebral body, they significantly reduce pain and improve the patient’s quality of life.
A specifically formulated cement used in vertebroplasty and kyphoplasty procedures to stabilize and support the spine's vertebrae that have been weakened by osteoporosis or other pathologies. This minimally invasive treatment provides immediate pain relief and strengthens the bone.